Morphosys (MOR) Stock Price, News & Analysis
Company Description
Morphosys (NASDAQ: MOR) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector. The company has a market capitalization of $2.9B, ranking #2,002 among all listed U.S. companies by market cap.
MOR stock has declined 100.0% over the past year. Shares last traded at $18.64.
This page provides a comprehensive overview of MOR stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Morphosys (MOR) stock last traded at $18.64. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $2.9B, MOR is classified as a mid-cap stock with approximately 150.7M shares outstanding.
MOR Rankings
Latest News
Morphosys has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 2 with negative movement. Key topics include acquisition, earnings, conferences, clinical trial. View all MOR news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Days to Cover History
MOR Company Profile & Sector Positioning
Morphosys (MOR) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.